Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer

Little is known about the etiology of in situ ductal breast cancer (DCIS) or what influences its possible progression to invasive ductal disease. Comparison of risk factors for DCIS and invasive ductal cancer may throw some light on these issues. We estimated relative risks for DCIS and invasive ductal breast cancer according to 12 genetic and eight environmental risk factors among 1.1 million postmenopausal women in a large prospective UK study. There was no strong evidence of a different association with DCIS versus invasive ductal cancer for any of the 12 susceptibility loci examined. We also found similar associations of age at menarche, age at first birth, parity, age at menopause, family history of breast cancer and use of hormone replacement therapy with DCIS and invasive ductal cancer. Only body mass index (BMI) showed a clear difference in association in that it was positively associated with the risk of invasive ductal cancer but not DCIS (RRs per 5 kg/m2 = 1.20 and 1.01, respectively; p‐value for heterogeneity = 0.002). The very similar risk factor profiles observed here for DCIS and invasive ductal cancer suggest that DCIS is a precursor of invasive ductal cancer and most risk factors affect the risk of invasive ductal cancer primarily through their effects on the risk of DCIS. The lack of association between BMI and DCIS suggests a greater influence of BMI on disease progression.

[1]  R. Hoover,et al.  Epidemiology of minimal breast cancer. , 1983, JAMA.

[2]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[3]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[4]  D. Brogan,et al.  Epidemiology of in situ and invasive breast cancer in women aged under 45. , 1996, British Journal of Cancer.

[5]  E A Sickles,et al.  Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. , 1997, Journal of the National Cancer Institute.

[6]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[7]  V. Beral,et al.  Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. , 2010, JAMA.

[8]  E. White,et al.  Short Communication Relationship between Age Maximum Height Is Attained, Age at Menarche, and Age at First Full-Term Birth and Breast Cancer Risk , 2007 .

[9]  K. Hemminki,et al.  Population attributable risks for breast cancer in Swedish women by morphological type , 2008, Breast Cancer Research and Treatment.

[10]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[11]  M. Morrow.  Pre-cancerous breast lesions: implications for breast cancer prevention trials. , 1992, International journal of radiation oncology, biology, physics.

[12]  W. Willett,et al.  Breast cancer (2). , 1992, The New England journal of medicine.

[13]  F. Clavel-Chapelon,et al.  Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC) , 2004, International journal of cancer.

[14]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[15]  P L Remington,et al.  Risk factors for carcinoma in situ of the breast. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  M. Longnecker,et al.  Risk factors for in situ breast cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  P. Nasca,et al.  Alcohol consumption and breast cancer: estrogen receptor status and histology. , 1994, American journal of epidemiology.

[18]  M. Longnecker,et al.  Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[20]  M. Melbye,et al.  A comparison of reproductive risk factors for CIS lesions and invasive breast cancer , 2004, International journal of cancer.

[21]  D. Black.  HEALTH AND DEPRIVATION: Inequality and the north , 1988 .

[22]  M. Pike,et al.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[23]  P. Crosignani.  Breast cancer and hormone-replacement therapy in the Million Women Study. , 2003, Maturitas.

[24]  L. Bernstein,et al.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort , 2010, Breast Cancer Research.

[25]  V. Beral,et al.  Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. , 2006, The Lancet. Oncology.

[26]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[27]  V. Beral,et al.  Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis , 2009, British Journal of Cancer.

[28]  M. Thun,et al.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.

[29]  M. Uehara,et al.  Acquisition of drug resistance by constitutive suppression of NF-kappaB in ras-transformed NIH3T3 mouse fibroblasts. , 2003, International journal of oncology.

[30]  N. Keiding,et al.  Multi-state models for event history analysis , 2002, Statistical methods in medical research.

[31]  Berta M. Geller,et al.  Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women , 2007, Breast Cancer Research and Treatment.

[32]  Mary Wilson,et al.  Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study , 2004, BMJ : British Medical Journal.